These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23549465)

  • 1. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L
    Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin.
    Tataroglu C; Karabacak T; Apa DD
    Tumori; 2007; 93(3):284-9. PubMed ID: 17679465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.
    Kacar A; Arikok AT; Kokenek Unal TD; Onder E; Hucumenoglu S; Alper M
    Pathol Oncol Res; 2012 Jan; 18(1):25-31. PubMed ID: 21674250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.
    Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM
    J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR; Chow P
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
    Berger F; Geddert H; Faller G; Werner M; Dimmler A
    Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
    Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA; Ross JS; Boehm JR; Carlson JA
    J Cutan Pathol; 1999 Sep; 26(8):391-7. PubMed ID: 10551411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry.
    Richey JD; Deng AC; Dresser K; O'Donnell P; Cornejo KM
    J Cutan Pathol; 2018 Aug; 45(8):603-609. PubMed ID: 29726030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.